(HealthDay News) — Here are the latest clinical trials, courtesy of CenterWatch:

Epilepsy

Candidates for this trial are adults with partial-onset epilepsy for whom at least three antiepileptic drugs have proven ineffective. They will have had an average of six or more seizures per month. Candidates will continue to receive their epilepsy medications while participating in the trial. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat62.html.

—–

Allergy

If you suffer from vasomotor rhinitis you may be eligible for a research study testing an investigational nasal spray. Vasomotor rhinitis is a condition where you have allergy symptoms such as stuffy nose, runny nose, or postnasal drip, but have negative reactions to allergy skin tests. Must be age 12 or older, non-smoker and in good health. Research site located in Minneapolis, Minn.

More Information

Please see http://www.centerwatch.com/patient/studies/cat166.html.

—–

Cancer/Chemotherapy

This study will compare the efficacy of darbepoetin alfa extended dose schedule administration (EDS) versus darbepoetin alfa administered once per week (QW) in the treatment of anemia in people with non-myeloid malignancies receiving multi-cycle chemotherapy. Study leaders are looking for men and women at least 18 years of age with active non-myeloid malignancy (cies) including lymphocytic leukemias. Research site located in New Albany, Ind.

More Information

Please see http://www.centerwatch.com/patient/studies/cat423.html.

—–

Copyright companies 2005 CenterWatch. All rights reserved.